Coy DH - Search Results

1

Examination of the 1,4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue design.

Sun L, Vasilevich NI, Fuselier JA, Hocart SJ, Coy DH. Sun L, et al. Among authors: coy dh. Bioorg Med Chem Lett. 2004 May 3;14(9):2041-6. doi: 10.1016/j.bmcl.2004.02.050. Bioorg Med Chem Lett. 2004. PMID: 15080975

2

Effects of camptothecin conjugated to a somatostatin analog vector on growth of tumor cell lines in culture and related tumors in rodents.

Sun L, Fuselier JA, Coy DH. Sun L, et al. Among authors: coy dh. Drug Deliv. 2004 Jul-Aug;11(4):231-8. doi: 10.1080/10717540490446125. Drug Deliv. 2004. PMID: 15371104 Free article.

3

A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.

Sun LC, Luo J, Mackey LV, Fuselier JA, Coy DH. Sun LC, et al. Among authors: coy dh. Cancer Lett. 2007 Feb 8;246(1-2):157-66. doi: 10.1016/j.canlet.2006.02.016. Epub 2006 Apr 27. Cancer Lett. 2007. PMID: 16644105

4

An adjustable release rate linking strategy for cytotoxin-peptide conjugates.

Fuselier JA, Sun L, Woltering SN, Murphy WA, Vasilevich N, Coy DH. Fuselier JA, et al. Among authors: coy dh. Bioorg Med Chem Lett. 2003 Mar 10;13(5):799-803. doi: 10.1016/s0960-894x(03)00016-7. Bioorg Med Chem Lett. 2003. PMID: 12617894

5

Abilities of 3,4-diarylfuran-2-one analogs of combretastatin A-4 to inhibit both proliferation of tumor cell lines and growth of relevant tumors in nude mice.

Sun L, Vasilevich NI, Fuselier JA, Coy DH. Sun L, et al. Among authors: coy dh. Anticancer Res. 2004 Jan-Feb;24(1):179-86. Anticancer Res. 2004. PMID: 15015595 Free article.

6

Three-dimensional quantitative structure-activity relationships of somatostatin analogues. 1. Comparative molecular field analysis of growth hormone release-inhibiting potencies.

Hocart SJ, Reddy V, Murphy WA, Coy DH. Hocart SJ, et al. Among authors: coy dh. J Med Chem. 1995 May 26;38(11):1974-89. doi: 10.1021/jm00011a017. J Med Chem. 1995. PMID: 7783129

7

Highly potent cyclic disulfide antagonists of somatostatin.

Hocart SJ, Jain R, Murphy WA, Taylor JE, Coy DH. Hocart SJ, et al. Among authors: coy dh. J Med Chem. 1999 Jun 3;42(11):1863-71. doi: 10.1021/jm9806289. J Med Chem. 1999. PMID: 10354394

8

Highly potent and subtype selective ligands derived by N-methyl scan of a somatostatin antagonist.

Rajeswaran WG, Hocart SJ, Murphy WA, Taylor JE, Coy DH. Rajeswaran WG, et al. Among authors: coy dh. J Med Chem. 2001 Apr 12;44(8):1305-11. doi: 10.1021/jm0005048. J Med Chem. 2001. PMID: 11312929

9

Analogues of growth hormone-releasing factor (1-29) amide containing the reduced peptide bond isostere in the N-terminal region.

Hocart SJ, Murphy WA, Coy DH. Hocart SJ, et al. Among authors: coy dh. J Med Chem. 1990 Jul;33(7):1954-8. doi: 10.1021/jm00169a022. J Med Chem. 1990. PMID: 2141879

10

Effects of camptothecin on tumor cell proliferation and angiogenesis when coupled to a bombesin analog used as a targeted delivery vector.

Sun LC, Luo J, Mackey VL, Fuselier JA, Coy DH. Sun LC, et al. Among authors: coy dh. Anticancer Drugs. 2007 Mar;18(3):341-8. doi: 10.1097/CAD.0b013e32801261b6. Anticancer Drugs. 2007. PMID: 17264768

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

674 results

Search Page

Filters